Jonathan Leiken
Jonathan Leiken's purchase track record
Jonathan Leiken has no open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/12/2022 | DBD | $11K | pending | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Dollar Tree sees interest from high‑income shoppers amid uncertainty. Recent coverage notes that even higher‑income consumers are turning to Dollar Tree for lower‑cost alternatives as economic conditions remain uncertain. The shift suggests broader appeal for the retailer's value offering and may influence sales dynamics. The stock is currently trading with an RSI near 64 and close to a support level around $111.98.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Diebold Nixdorf partners stc pay Bahrain on digital‑physical services. Diebold Nixdorf announced a partnership with stc pay Bahrain to connect digital payment solutions with its physical financial service offerings. The collaboration aims to broaden the company’s reach in the Middle East by combining stc pay’s mobile platform with Diebold Nixdorf’s ATM and kiosk network. The firm also scheduled its 2026 third‑quarter investor call for Oct. 28, giving analysts an opportunity to discuss progress on converting its order backlog into cash.
Transaction History
| DHR | ▲ Buy | Grant | 2,374 | $0 | 3/1/2026 | View on chart |
| DHR | ▲ Buy | Grant | 10,172 | $0 | 11/15/2025 | View on chart |
| DLTR | ▼ Sell | Open Market | 177 | $13K | 4/1/2025 | View on chart |
| DLTR | ▼ Sell | Tax Withholding | 355 | $27K | 4/1/2025 | View on chart |
| DLTR | ▲ Buy | Grant | 16,591 | $0 | 4/1/2025 | View on chart |
| DLTR | ▼ Sell | Tax Withholding | 459 | $31K | 10/27/2024 | View on chart |
| DLTR | ▲ Buy | Grant | 3,531 | $0 | 4/1/2024 | View on chart |
| DLTR | ▲ Buy | Grant | 4,573 | $0 | 10/27/2023 | View on chart |
| DBD | ▼ Sell | Other | 249,370 | $0 | 8/11/2023 | View on chart |
| DBD | ▼ Sell | Tax Withholding | 13,682 | $44K | 3/8/2023 | View on chart |
| DBD | ▼ Sell | Tax Withholding | 2,688 | $7K | 2/5/2023 | View on chart |
| DBD | ▼ Sell | Tax Withholding | 3,368 | $8K | 1/30/2023 | View on chart |
| DBD | ▲ Buy | Open Market | 4,400 | $11K | 5/12/2022 | View on chart |
| DBD | ▲ Buy | Grant | 127,864 | $0 | 3/8/2022 | View on chart |
| DBD | ▼ Sell | Tax Withholding | 2,646 | $22K | 2/5/2022 | View on chart |
| DBD | ▼ Sell | Tax Withholding | 2,845 | $25K | 1/30/2022 | View on chart |
| DBD | ▼ Sell | Tax Withholding | 9,724 | $86K | 1/29/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Danaher Expands AI Integration in Scientific Research
Danaher has announced a partnership to integrate AI into scientific research workflows, a move that could enhance its diagnostic and drug discovery capabilities. With Q3 earnings approaching, investors are watching to see if this strategic shift supports the company's recovery narrative. The stock currently trades near its 52-week high, reflecting optimism about these operational improvements.
Danaher Expands AI Integration in Scientific Research. Danaher has announced a partnership to integrate AI into scientific research workflows, a move that could enhance its diagnostic and drug discovery capabilities. With Q3 earnings approaching, investors are watching to see if this strategic shift supports the company's recovery narrative. The stock currently trades near its 52-week high, reflecting optimism about these operational improvements.